protein
| interacting with HSPA9 through N-terminal region of HSPA9 |
|
(involvement in tumorigenesis, functional distinction in pathways involved in senescence) |
|
binding to YBX1 in the cytoplasm and acting as a regulator of polysome association and subellular distribution of YBX1 (Ohashi 2009) |
|
HSPD1 is a novel regulator of mitochondrial permeability transition, contributing to a cytoprotective chaperone network that antagonizes PPIF-dependent cell death in tumors |
|
OLR1 through binding to extracellular HSPD1 promotes microglia-mediated neuroinflammation |
|
LEP plays an important role in mitochondrial function and insulin sensitivity in the hypothalamus by regulating HSPD1 |
|
HSPD1 and SOD2 proteins interact (SOD2 likely is a substrate of the HSPD1 folding machinery and under conditions of diminished availability of HSPD1, SOD2 is impaired in reaching the native state |
|
HSPD1 interacted with IRF3 and it contributed to the induction of IFNB1 |
|
FUS interacts with a mitochondrial chaperonin, HSPD1, and FUS translocation to mitochondria is, at least in part, mediated by HSPD1 |
|
is involved in the stimulation of VSMC migration, via TLR4 and ERK MAPK activation |
|
co-chaperone for HSPD1, which is involved in the mitochondrial protein-folding machinery |
|
showed pro-inflammatory properties in bronchial epithelial cells mediated by activation of TLR4-related molecules |
|
possesses a GTPase activity and mediates protein folding with HSPE1 |
|
VSMC proliferation can be modulated via an HSPD1 dependent, cytosol localized mechanism that in part involves a stimulation of nuclear protein import through an interaction with RAN |
|
induces the phosphorylation and nuclear localization of NFKB1 |
|
HSPD1 further activates NLRP3 inflammasome by elevating NLRP3 expression both at RNA and protein levels |
|
HSPD1 negatively regulates the biological functions of ubiquitin-like protein FAU in macrophages |
|
HSPD1 might repress CDH1 expression and promote metastatic characters of Buccal mucosa squamous cell carcinoma (BMSCC) cells for poor prognosis of BMSCC patients |